戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 esions, in apoptotic cells, and circulate in oxidized low density lipoprotein.
2 ent for neointima formation by components of oxidized low density lipoprotein.
3 es for the SR-A-mediated cell association of oxidized low density lipoprotein.
4 nhibited mesangial cell apoptosis induced by oxidized low density lipoprotein.
5 c cholesterol efflux and decreased uptake of oxidized low density lipoprotein.
6  T cells and an IgG1 isotype response toward oxidized low-density lipoprotein.
7 n of p38 mitogen-activated protein kinase by oxidized low-density lipoprotein.
8 nds that influence oxidative stress, such as oxidized low-density lipoprotein.
9 idation and measurement of autoantibodies to oxidized low-density lipoprotein.
10 e and specific assays to measure circulating oxidized low-density lipoprotein.
11  scavenger receptor ligands, acetylated, and oxidized low-density lipoprotein.
12 ta3 receptor ligation restores the uptake of oxidized low-density lipoprotein.
13 es most significantly with markers of plasma-oxidized low-density lipoprotein.
14  associated with blood glucose, but not with oxidized low-density lipoprotein.
15 rombospondin-1, collagen types I and IV, and oxidized low-density lipoprotein.
16 result of inhibition of atherogenic forms of oxidized low-density lipoprotein.
17 ion complexity and colocalized with C5aR and oxidized low-density lipoprotein.
18            We found 328 SNPs associated with oxidized low-density lipoprotein.
19  against bacterial phosphorylcholine but not oxidized low-density lipoprotein.
20 osition or in the serum antibody response to oxidized low-density lipoprotein.
21 therosclerotic lesions, apoptotic cells, and oxidized low density lipoproteins.
22                     Exposure of monocytes to oxidized low-density lipoprotein, 7-ketocholesterol, pho
23 c CD4(+) T cells and had IgG2a antibodies to oxidized low-density lipoprotein (a disease-related anti
24 B scavenger receptor, binds and internalizes oxidized low density lipoprotein, a key event in the dev
25 ions arise from lipid oxidation and generate oxidized low-density lipoprotein, a powerful inflammator
26                                              Oxidized low-density lipoprotein accumulates in atherosc
27 nt of plasma triglyceride-rich lipoproteins, oxidized low-density lipoproteins, adipokines, and cytok
28 so inhibited CD36 mRNA expression induced by oxidized low density lipoprotein and 15-deoxyDelta(12,14
29 ges, CXCL16 promoted internalization of both oxidized low density lipoprotein and high density lipopr
30 rotein has a wide range of ligands including oxidized low density lipoprotein and long chain fatty ac
31 -Asp-Ser and anti-alpha(v), and up to 20% by oxidized low density lipoprotein and N-acetylglucosamine
32 rythrocytes, and as a scavenger receptor for oxidized low-density lipoprotein and apoptotic neutrophi
33 cavenger receptor, binding and internalizing oxidized low-density lipoprotein and bacteria.
34 ystems because the same protein domain binds oxidized low-density lipoprotein and bacterial cell wall
35 onses on stimulation by interferon-gamma and oxidized low-density lipoprotein and elevated antioxidan
36 d 2012-2014) over 24 years and had assays of oxidized low-density lipoprotein and fundus photographs
37  the growing body of evidence on circulating oxidized low-density lipoprotein and its relationship to
38 ry that macrophage COX-2 is downregulated by oxidized low-density lipoprotein and liver X receptors i
39 xidation-specific epitopes, such as those on oxidized low-density lipoprotein and malondialdehyde-mod
40 including preventing inflammation induced by oxidized low-density lipoprotein and promoting apoptotic
41 performed a genome-wide association study on oxidized low-density lipoprotein and tested the impact o
42 ationship between increasing levels of serum oxidized low-density lipoprotein and the incidence of ma
43 tabolic signaling by proline oxidase between oxidized low-density lipoproteins and autophagy provides
44 gamma-responsive genes, CD36, a receptor for oxidized low density lipoprotein, and aP2, a fatty acid-
45 ension, high-sensitivity C-reactive protein, oxidized low-density lipoprotein, and low high-density l
46 lial barrier dysfunction caused by thrombin, oxidized low-density lipoprotein, and tumor necrosis fac
47 venger receptors that mediate endocytosis of oxidized low-density lipoproteins, and adhesion to gluco
48  have also suggested that elevated levels of oxidized low-density lipoprotein are a prognostic indica
49             Atherogenic lipids, particularly oxidized low-density lipoprotein, are responsible for a
50 bit apoptosis in culture upon treatment with oxidized low density lipoprotein, as do vascular cells o
51  factors, we found that neither the level of oxidized low-density lipoprotein at the beginning of a p
52  will further assess the clinical utility of oxidized low-density lipoprotein biomarkers by determini
53                      Research on circulating oxidized low-density lipoprotein biomarkers is rapidly a
54 bution of endothelial JAM-A was increased by oxidized low-density lipoprotein, but confined by athero
55 e scavenger receptor CD36, mediate uptake of oxidized low density lipoprotein by macrophages, and pro
56 ally, it has been assumed that the uptake of oxidized low-density lipoprotein by macrophage scavenger
57 in Fab from a patient with autoantibodies to oxidized low-density lipoproteins by phage display metho
58 ulse-wave velocity, intima-media thickening, oxidized low-density lipoprotein, Ca(2+) deposits, and g
59 oline (lysoPC), a major lipid constituent of oxidized low-density lipoprotein, can activate PKC and i
60  (LOX-1), one of the scavenger receptors for oxidized low-density lipoprotein cholesterol (ox-LDL), p
61                                              Oxidized low-density lipoprotein cholesterol is harmful
62 oam cell formation by reducing acetylated or oxidized low-density lipoprotein cholesterol uptake in d
63 ing, are amplified by the harmful effects of oxidized low-density-lipoprotein cholesterol, initiating
64 benefits of exercise, as serum triglyceride, oxidized low density lipoprotein-cholesterol, and plasma
65                                The levels of oxidized low-density lipoprotein collected from serum sa
66 x immobilized proteins: complement factor H, oxidized low-density lipoprotein, complement C3b, IgG, a
67 re originally selected for binding to copper-oxidized low-density lipoproteins (CuOx-LDL), also bound
68  restores endothelial function, and prevents oxidized low-density lipoprotein-dependent increases in
69 n, suppressed CD36 expression, and prevented oxidized low-density lipoprotein-derived cholesterol upt
70                   Exposure of macrophages to oxidized low-density lipoprotein downregulated LKB1 in v
71                       Like histamine, highly oxidized low-density lipoprotein, especially the oxidize
72  as a receptor for thrombospondin, collagen, oxidized low density lipoprotein, fatty acids, anionic p
73 phenotype and subsequently treated them with oxidized low density lipoprotein for various time period
74 s involved in the accumulation and efflux of oxidized low density lipoprotein in the arterial wall.
75 but phagocytosis is significantly reduced by oxidized low-density lipoprotein in vitro or hyperlipide
76 xposed to bacterial lipopolysaccharide or to oxidized low-density lipoprotein in vitro, and this coul
77  of LOX-1, a lectin-like 52-kDa receptor for oxidized low density lipoprotein, in TGFbeta(1)-mediated
78                                              Oxidized low-density lipoproteins increase arginase acti
79 biologically active lipids present in mildly oxidized low density lipoprotein, increased apolipoprote
80 t time that both low density lipoprotein and oxidized low density lipoprotein induce tissue factor ge
81 16 deficiency in macrophages interfered with oxidized low density lipoprotein-induced up-regulation o
82 c reticulum stress, increased sensitivity to oxidized low-density lipoprotein-induced apoptosis, and
83  truncated SIRT1 (Deltaex4) showed increased oxidized low-density lipoprotein-induced DNA damage and
84                                              Oxidized low-density lipoprotein induces inflammation as
85 at macrophage PI3-kinase/Akt is activated by oxidized low-density lipoprotein, inflammatory chemokine
86                Growth factors, cytokines and oxidized low density lipoproteins influence proteoglycan
87 ciated phospholipase A2 (Lp-PLA2) hydrolyses oxidized low-density lipoproteins into proinflammatory p
88 e hypothesis that the apoptotic component of oxidized low density lipoprotein is one or more oxystero
89 opulations has demonstrated that circulating oxidized low-density lipoprotein is associated with prec
90 Immunity, Lim et al. (2014) demonstrate that oxidized low-density lipoprotein is one of the key envir
91 w-risk interventions are available to modify oxidized low-density lipoprotein, it is important to exa
92       Standard lipid moieties and markers of oxidized low density lipoprotein (LDL) (immunoglobulin G
93                We have previously shown that oxidized low density lipoprotein (LDL) but not native LD
94                                              Oxidized low density lipoprotein (LDL) may be of central
95  Moreover, incubating human macrophages with oxidized low density lipoprotein (LDL) or acetylated LDL
96 ltifunctional receptor whose ligands include oxidized low density lipoprotein (LDL), as well as sever
97 e have previously identified a 94- to 97-kDa oxidized low density lipoprotein (LDL)-binding protein i
98                                              Oxidized low density lipoprotein (LDL; oxLDL) causes dis
99 that coincubation of SMC with macrophages or oxidized low density lipoproteins (LDL) from macrophage-
100 e, deposition of the altered self components oxidized low-density lipoprotein (LDL) and amyloid-beta
101 e highly susceptible to the toxic effects of oxidized low-density lipoprotein (LDL) and exhibit marke
102                           Oxidant stress and oxidized low-density lipoprotein (LDL) impair endothelia
103                          We demonstrate that oxidized low-density lipoprotein (LDL) induces surface t
104                                              Oxidized low-density lipoprotein (LDL) is an important d
105                                              Oxidized low-density lipoprotein (LDL) is implicated in
106 nitric oxide (NO) levels and increased serum-oxidized low-density lipoprotein (LDL) levels compared t
107            We investigated whether levels of oxidized low-density lipoprotein (LDL) measured with use
108 dothelial cells were treated with cytokines, oxidized low-density lipoprotein (LDL) or fatty acids.
109                                              Oxidized low-density lipoprotein (LDL) plays an essentia
110 both very low-density lipoprotein (VLDL) and oxidized low-density lipoprotein (LDL) support assembly
111        Soluble endogenous ligands, including oxidized low-density lipoprotein (LDL), amyloid-beta and
112 an atherogenic lysophospholipid contained in oxidized low-density lipoprotein (LDL), has been shown t
113 ha-tocopherol (mumol/mmol lipid) and greater oxidized low-density lipoprotein (LDL), interleukin (IL)
114   Here, we investigated the role of JAM-C in oxidized low-density lipoprotein (LDL)-mediated leukocyt
115 hersclerosis, and that such antibodies bound oxidized low-density lipoproteins (LDL) (oxLDL) in ather
116                                     Elevated oxidized low-density lipoproteins (LDL) are associated w
117  pro-inflammatory oxidized lipids present in oxidized low-density lipoproteins (LDLs).
118 oliferative retinopathy, with an increase in oxidized low-density lipoprotein level over the precedin
119 tic marker is an important factor regulating oxidized low-density lipoprotein levels but not a major
120                                        Serum-oxidized low-density lipoprotein levels were directly as
121                                  Lectin-like oxidized low-density lipoprotein (LOX-1), the primary re
122 n of lysophosphatidylcholine, a component of oxidized low density lipoprotein, markedly decreased apo
123                                              Oxidized low-density lipoprotein may be a key factor in
124 sted that autoantibodies against epitopes of oxidized low-density lipoprotein may indicate the extent
125 d-containing phospholipids present in mildly oxidized low density lipoproteins (MM-LDL) can activate
126  recognizes modified self, such as minimally oxidized low-density lipoprotein (mmLDL).
127  cohort at baseline had a mean (SD) level of oxidized low-density lipoprotein of 30.0 (8.5) U/L.
128 ysiological stimuli, native (unmodified) and oxidized low density lipoprotein, on tissue factor gene
129 exposed to macrophages rendered apoptotic by oxidized low density lipoprotein or UV radiation.
130                                         Both oxidized low density lipoprotein (ox-LDL) and platelet-d
131 es VSMC accumulation even in the presence of oxidized low density lipoprotein (Ox-LDL).
132 f the response of macrophages to exposure to oxidized low density lipoprotein (Ox-LDL).
133 gments and scavenging of apoptotic cells and oxidized low density lipoprotein (Ox-LDL).
134                                              Oxidized low density lipoproteins (Ox-LDL) affect severa
135 vestigated whether inflammatory cytokines or oxidized low density lipoproteins (Ox-LDL) present in hu
136 ls surface-bound, internalized, and degraded oxidized low density lipoproteins (Ox-LDL).
137                                              Oxidized low-density lipoprotein (ox-LDL) causes endothe
138 ipoprotein (LOX-1), the primary receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial
139                   In the general population, oxidized low-density lipoprotein (ox-LDL) increases the
140                                              Oxidized low-density lipoprotein (ox-LDL) induces apopto
141  this study were to test our hypothesis that oxidized low-density lipoprotein (ox-LDL) induces the re
142 ein receptors (LOX-1), a recently identified oxidized low-density lipoprotein (ox-LDL) receptor, in i
143 -derived macrophages cultured in vitro under oxidized low-density lipoprotein (ox-LDL) stimulation.
144                                              Oxidized low-density lipoprotein (ox-LDL) up-regulates C
145 teins, oxidized state, and autoantibodies to oxidized low-density lipoprotein (Ox-LDL) were assessed.
146                                              Oxidized low-density lipoprotein (ox-LDL), an atherogeni
147  hydrogen sulfide (H2S) in the generation of oxidized low-density lipoprotein (ox-LDL)-stimulated mon
148  locally produced inflammatory cytokines and oxidized low-density lipoprotein (Ox-LDL).
149 function induced by cholesterol crystals and oxidized low-density lipoproteins (ox-LDL), potentially
150 spholipid antibodies (aPL) and antibodies to oxidized low-density lipoproteins (ox-LDL).
151 amined its expression pattern in response to oxidized low-density lipoproteins (ox-LDLs) that are bel
152                                       Plasma oxidized low-density lipoprotein (oxi-LDL), a measure of
153      We have shown previously that minimally oxidized low density lipoprotein, oxidized 1-palmitoyl-2
154                                              Oxidized low density lipoprotein (oxLDL) and macrophage
155 re identified as critical for oxPC(CD36) and oxidized low density lipoprotein (oxLDL) binding to CD36
156                                The uptake of oxidized low density lipoprotein (OxLDL) by macrophages
157 tant physiological function in the uptake of oxidized low density lipoprotein (OxLDL) by macrophages.
158 an blood-derived macrophages pretreated with oxidized low density lipoprotein (OxLDL) fail to transcr
159  THP-1-derived macrophages were treated with oxidized low density lipoprotein (OxLDL) for 3 days to l
160  that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gen
161                                              Oxidized low density lipoprotein (oxLDL) induces apoptos
162                                              Oxidized low density lipoprotein (oxLDL) is inflammatory
163 of this study was to determine the effect of oxidized low density lipoprotein (oxLDL) on BMP-2 protei
164 he present study, we examined the effects of oxidized low density lipoprotein (oxLDL) on the subcellu
165                                              Oxidized low density lipoprotein (OxLDL) or lysophosphat
166 rmation initiated by exposing macrophages to oxidized low density lipoprotein (oxLDL) triggers the di
167  actively researched, with focuses on FA and oxidized low density lipoprotein (oxLDL) uptake.
168         We have previously demonstrated that oxidized low density lipoprotein (OxLDL) will increase e
169 avenger receptors (MSR) bind and internalize oxidized low density lipoprotein (OxLDL), a modified lip
170 rray of ligands, including thrombospondin-1, oxidized low density lipoprotein (OxLDL), fatty acids, a
171 cal impedance (EIS) increased in response to oxidized low density lipoprotein (oxLDL)-laden lesions.
172                We have shown previously that oxidized low density lipoproteins (OxLDL) also can inhib
173                                              Oxidized low density lipoproteins (oxLDL) are among the
174  cardiomyocytes and adipocytes and uptake of oxidized low density lipoproteins (oxLDL) by macrophages
175       Apoptosis of arterial cells induced by oxidized low density lipoproteins (OxLDL) is thought to
176                                              Oxidized low density lipoproteins (OxLDL) promote chroni
177                                              Oxidized low-density lipoprotein (OxLDL) also stimulates
178 s, autoantibodies are induced to epitopes of oxidized low-density lipoprotein (oxLDL) and active immu
179 reviously we showed that interaction between oxidized low-density lipoprotein (oxLDL) and CD36 inhibi
180 ured OxPL/apoB, lipoprotein (a) [Lp(a)], and oxidized low-density lipoprotein (OxLDL) biomarkers, con
181 evaluate the uptake of fluorescently labeled oxidized low-density lipoprotein (oxLDL) by a monocyte/m
182                                The uptake of oxidized low-density lipoprotein (OxLDL) by macrophage s
183 erosis and leads to the uptake of native and oxidized low-density lipoprotein (oxLDL) by macrophages
184 re under increased oxidative stress and that oxidized low-density lipoprotein (OxLDL) competes with a
185 nd smooth muscle cells (SMCs) to atherogenic oxidized low-density lipoprotein (oxLDL) enhances their
186                    We previously showed that oxidized low-density lipoprotein (oxLDL) formed in the s
187 IgM autoantibodies which bind to epitopes of oxidized low-density lipoprotein (OxLDL) from apoE-defic
188                                              Oxidized low-density lipoprotein (oxLDL) has been report
189 rotect against atherosclerosis, whereas anti-oxidized low-density lipoprotein (oxLDL) IgG likely prom
190                                              Oxidized low-density lipoprotein (OxLDL) impairs NO sign
191 f scavenger receptor (SR)-mediated uptake of oxidized low-density lipoprotein (OxLDL) in atherogenesi
192 he neurotoxicity associated with exposure to oxidized low-density lipoprotein (oxLDL) in vitro, we te
193       Therefore, this study analyzed whether oxidized low-density lipoprotein (oxLDL) induces CD40/CD
194                               Proatherogenic oxidized low-density lipoprotein (oxLDL) induces endothe
195   Our aim was to examine whether circulating oxidized low-density lipoprotein (oxLDL) is a predictor
196                                              Oxidized low-density lipoprotein (oxLDL) is considered o
197 in human aortic endothelial cells exposed to oxidized low-density lipoprotein (OxLDL) is consistent w
198                                              Oxidized low-density lipoprotein (oxLDL) is known to act
199                         Macrophage uptake of oxidized low-density lipoprotein (oxLDL) is thought to p
200   This study was performed to assess whether oxidized low-density lipoprotein (OxLDL) levels are elev
201   However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice
202  receptor CD36 recognizes oxidized lipids in oxidized low-density lipoprotein (oxLDL) particles, a pr
203                                              Oxidized low-density lipoprotein (oxLDL) promotes unregu
204 o test the hypothesis that plasma markers of oxidized low-density lipoprotein (OxLDL) reflect acute c
205 tural prooxidant and proatherogenic molecule oxidized low-density lipoprotein (OxLDL) to determine a
206 as been shown previously that the binding of oxidized low-density lipoprotein (OxLDL) to resident mou
207                                    In vitro, oxidized low-density lipoprotein (OxLDL), a key factor i
208 lerotic plaques by antibodies that recognize oxidized low-density lipoprotein (OxLDL), but none have
209                                              Oxidized low-density lipoprotein (oxLDL), but not native
210 at contrary to the prothrombotic activity of oxidized low-density lipoprotein (OxLDL), HDL upon oxida
211                                     Retained oxidized low-density lipoprotein (oxLDL), in turn, stimu
212  and macrophages to beta-amyloid fibrils and oxidized low-density lipoprotein (oxLDL)-coated surfaces
213 eport a novel mechanistic connection between oxidized low-density lipoprotein (oxLDL)-induced prothro
214 acterial antigens and human antigens such as oxidized low-density lipoprotein (oxLDL).
215 ylated low-density lipoprotein (glycLDL) and oxidized low-density lipoprotein (oxLDL).
216 ion of scavenger receptors and the uptake of oxidized low-density lipoprotein (oxLDL).
217 receptors that internalize lipids, including oxidized low-density lipoprotein (oxLDL).
218 bly inhibited by antibodies directed against oxidized low-density lipoprotein (oxLDL).
219 ce they are in low abundance in samples like oxidized low-density lipoproteins (OxLDL) and human plas
220 elopment by facilitating the accumulation of oxidized low-density lipoproteins (oxLDL) and increasing
221                                The uptake of oxidized low-density lipoproteins (oxLDL) by macrophages
222                                              Oxidized low-density lipoproteins (oxLDL) generated in t
223 ly in response to exposure to an NO donor or oxidized low-density lipoproteins (oxLDL) increases p21r
224  and in endothelial cells (ECs) treated with oxidized low-density lipoproteins (oxLDL).
225                                       In the oxidized low-density-lipoprotein (oxLDL)-rich lesions fr
226 poE(-/-) mice; and 3) proatherogenic lipids (oxidized low density lipoprotein [oxLDL] and oxidized li
227                                              Oxidized low-density lipoproteins (OxLDLs), in particula
228 ) or smooth muscle cell (SMC) contact and by oxidized low-density lipoproteins (oxLDLs).
229                                              Oxidized low-density lipoprotein, oxysterols, and synthe
230 ost common phospholipid oxidation product of oxidized low density lipoprotein, phosphatidylcholine wi
231 tumor spread, invasion and angiogenesis, and oxidized low-density lipoprotein, playing a role in inhi
232                                              Oxidized low-density lipoprotein plays a key role in the
233                                              Oxidized low-density lipoprotein plays a major role in a
234 orroborated the contributing role of C5l2 in oxidized low-density lipoprotein-pretreated C5a-induced
235 ude that macrophage LKB1 reduction caused by oxidized low-density lipoprotein promotes foam cell form
236 e entire intracellular domain of lectin-like oxidized low density lipoprotein receptor 1 or SR expres
237  three members of the SR family (lectin-like oxidized low density lipoprotein receptor 1; fasciclin,
238                              The lectin-like oxidized low density lipoprotein receptor-1 (Lox-1) medi
239 ger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the n
240 telet-activating factor acetylhydrolase, and oxidized low-density lipoprotein receptor 1 (OLR1).
241 ombosis; and (99m)Tc-labeled anti-lectinlike oxidized low-density lipoprotein receptor 1 antibody, wh
242 tor 1 antibody, which detects the lectinlike oxidized low-density lipoprotein receptor 1 that is over
243  foamy niche within macrophage by modulating oxidized low-density lipoprotein receptor CD36, phagolys
244                                  Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a
245 avenger receptor type AI/AII and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) was
246                                  Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), one
247  expression of CD36, SR-BII, and lectin-like oxidized low-density lipoprotein receptor-1 were down-re
248                           LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1), a membrane
249  CD36 and CD68, SR-A and SR-BII, lectin-like oxidized low-density lipoprotein receptor-1, the nuclear
250 udy was to determine the role of lectin-like oxidized low-density lipoprotein receptors (LOX-1), a re
251                                  Lectin-like oxidized low-density lipoprotein receptors are upregulat
252                                              Oxidized low-density lipoprotein reduces endothelial nit
253                               Application of oxidized low-density lipoprotein resulted in an increase
254                                   Native and oxidized low density lipoprotein retention within arteri
255  risk factors, including serum nitric oxide, oxidized low-density lipoprotein, serum amyloid A, and l
256 mice, which have high autoantibody titers to oxidized low density lipoprotein, showed a striking time
257 ough induction of IL-5-producing T cells and oxidized low-density lipoprotein-specific IgM and reduct
258 s increased, thus enhancing atheroprotective oxidized low-density lipoprotein-specific IgM production
259 Autoantibodies recognizing model epitopes of oxidized low density lipoprotein, such as malondialdehyd
260 oxy-delta prostaglandin J2 and components of oxidized low-density lipoprotein, such as 13-hydroxyocta
261 n was blocked 50% by PS liposomes and 40% by oxidized low density lipoprotein, suggesting that the ma
262                           Studies have shown oxidized low-density lipoprotein to be associated with t
263 bolites, isoprostanes) and autoantibodies to oxidized low-density lipoprotein to risk for atheroscler
264 erotic lesions and that in vitro exposure to oxidized low-density lipoprotein up-regulates alphaVbeta
265 ired for 15(S)-HETE-induced CD36 expression, oxidized low density lipoprotein uptake, and foam cell f
266 and induced monocyte lipid accumulation from oxidized low-density lipoprotein via the CD36 scavenger
267 ignificant decrease in binding and uptake of oxidized low density lipoprotein was observed in periton
268 xpression in rat aortic smooth muscle cells; oxidized low density lipoprotein was slightly more poten
269 bility to inactivate lipid hydroperoxides in oxidized low-density lipoprotein was carried predominant
270 lipoprotein-associated phospholipase A2, and oxidized low-density lipoprotein were assessed in a subg
271 cavenger receptor for phosphatidylserine and oxidized low-density lipoprotein were independently iden
272 cavenger receptor for phosphatidylserine and oxidized low density lipoprotein, which is highly expres
273                                              Oxidized low-density lipoprotein, which plays a central

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top